Santhera and ReveraGen to Present Findings from Pivotal VISION-DMD Study with Vamorolone at ...

Retrieved on: 2021-06-24 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Santhera and ReveraGen to Present Findings from Pivotal VISION-DMD Study with Vamorolone at .... View article details on hiswai:

Excerpt

Pratteln, Switzerland, and Rockville, MD, USA,June 24, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc (US: private) ...

Article found on: www.biospace.com